Orally Active CCR5 Antagonists as anti‐HIV‐1 Agents. Part 2. Synthesis and Biological Activities of Anilide Derivatives Containing a Pyridine N‐Oxide Moiety | NobleID
v1
Orally Active CCR5 Antagonists as anti‐HIV‐1 Agents. Part 2. Synthesis and Biological Activities of Anilide Derivatives Containing a Pyridine N‐Oxide Moiety.
Masaki Seto, Yoshio Aramaki, Hiroshi Imoto, Katsuji Aikawaand 5 more
